Sector ratings Gedeon Richter LUXEMBOURG S.E.

Stocks

End-of-day quote LUXEMBOURG S.E. 2026-10-02			5-day change	1st Jan Change
38.00 ^USD	0.00%		-2.56%	+25.83%

09-18	EU Medicines Agency Panel Issues Positive Opinion on Gedeon Richter's Arthritis Drug	MT
08-11	Gedeon Richter PLC, Q2 2026 Earnings Call, Aug 07, 2026

Add to a list 0 selected To use this feature you must be a member Log in Sign up	Capi.($)	Investor	ESG MSCI	Fundamentals	Global Valuation
ELI LILLY AND COMPANY	1,019B		A
JOHNSON & JOHNSON	617B		BBB
ABBVIE INC.	464B		AAA		-
MERCK & CO., INC.	356B		A
ROCHE HOLDING AG	333B		AA
NOVARTIS AG	267B		AAA
ASTRAZENECA PLC	244B		A
AMGEN INC.	218B		A
GILEAD SCIENCES, INC.	179B		AA
NOVO NORDISK A/S	166B		BBB
PFIZER INC.	158B		A
VERTEX PHARMACEUTICALS INCORPORATED	128B		AA
BRISTOL-MYERS SQUIBB COMPANY	125B		A
MCKESSON CORPORATION	105B	-	AA	-	-
SANOFI	95.48B		A
GSK PLC	94.34B		AA
MODERNA, INC.	75.86B	-	BBB	-	-
REGENERON PHARMACEUTICALS, INC.	73.41B		BBB
MERCK KGAA	66.99B		AAA
Average	251.87B		AA
Weighted average by Cap.			AA